🇺🇸 FDA
Patent

US 9207243

Use of GLUT4 inhibitors and DNA damaging agents for treating multiple myeloma

granted A61KA61K31/427A61K31/496

Quick answer

US patent 9207243 (Use of GLUT4 inhibitors and DNA damaging agents for treating multiple myeloma) held by Northwestern University expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/427, A61K31/496, A61K31/69, A61K31/704